# Parabolic Technologies, Inc.: financial statements, quarterly PARA · Nasdaq · CIK 1826011 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/para.md) · [Financials](/companies/para/financials.md) · [Filings](/companies/para/filings.md) · [Insiders](/companies/para/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/para/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1.1](/filings/0000950170-24-127232.md) | [1.1 d](/filings/0000950170-25-054303.md) | [1.1](/filings/0000950170-25-072501.md) | [1.1](/filings/0000950170-25-108855.md) | [1.1](/filings/0001193125-25-283006.md) | [1.3 d](/filings/0001193125-26-134714.md) | [3.4](/filings/0001193125-26-226795.md) | [3.1](/filings/0001193125-26-352362.md) | [2.8](/filings/0001193125-25-283006.md) | [2.8 d](/filings/0001193125-26-134714.md) | [2.7](/filings/0001193125-26-226795.md) | [2.3](/filings/0001193125-26-352362.md) | | Cost of revenue | $m | [0.3](/filings/0000950170-24-127232.md) | [0.3 d](/filings/0000950170-25-054303.md) | [0.4](/filings/0000950170-25-072501.md) | [0.3](/filings/0000950170-25-108855.md) | [0.3](/filings/0001193125-25-283006.md) | [0.4 d](/filings/0001193125-26-134714.md) | [0.6](/filings/0001193125-26-226795.md) | [0.6](/filings/0001193125-26-352362.md) | [0.5](/filings/0001193125-25-283006.md) | [0.5 d](/filings/0001193125-26-134714.md) | [0.5](/filings/0001193125-26-226795.md) | [0.5](/filings/0001193125-26-352362.md) | | Gross profit | $m | [0.8](/filings/0000950170-24-127232.md) | [0.8 d](/filings/0000950170-25-054303.md) | [0.7](/filings/0000950170-25-072501.md) | [0.7](/filings/0000950170-25-108855.md) | [0.7](/filings/0001193125-25-283006.md) | [0.9 d](/filings/0001193125-26-134714.md) | [2.8](/filings/0001193125-26-226795.md) | [2.6](/filings/0001193125-26-352362.md) | [2.3](/filings/0001193125-25-283006.md) | [2.3 d](/filings/0001193125-26-134714.md) | [2.2](/filings/0001193125-26-226795.md) | [1.8](/filings/0001193125-26-352362.md) | | Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating income | $m | [(2.1)](/filings/0000950170-24-127232.md) | [(3.2) d](/filings/0000950170-25-054303.md) | [(3.4)](/filings/0000950170-25-072501.md) | [(3.4)](/filings/0000950170-25-108855.md) | [(2.8)](/filings/0001193125-25-283006.md) | [(3.9) d](/filings/0001193125-26-134714.md) | [(4.9)](/filings/0001193125-26-226795.md) | [(4.8)](/filings/0001193125-26-352362.md) | [(4.4)](/filings/0001193125-25-283006.md) | [(4.3) d](/filings/0001193125-26-134714.md) | [(5.8)](/filings/0001193125-26-226795.md) | [(4.4)](/filings/0001193125-26-352362.md) | | Income tax | $m | [0.0](/filings/0000950170-24-127232.md) | [(0.0) d](/filings/0000950170-25-054303.md) | [(0.0)](/filings/0000950170-25-072501.md) | [0.0](/filings/0000950170-25-108855.md) | [0.0](/filings/0001193125-25-283006.md) | [(0.0) d](/filings/0001193125-26-134714.md) | [0.1](/filings/0001193125-26-226795.md) | [(0.2)](/filings/0001193125-26-352362.md) | [0.3](/filings/0001193125-25-283006.md) | [(0.1) d](/filings/0001193125-26-134714.md) | [(0.1)](/filings/0001193125-26-226795.md) | [(0.1)](/filings/0001193125-26-352362.md) | | Net income | $m | [(0.8)](/filings/0000950170-24-127232.md) | [(6.4) d](/filings/0000950170-25-054303.md) | [(4.3)](/filings/0001193125-25-283006.md) | [(4.0)](/filings/0001193125-25-283006.md) | [(15.4)](/filings/0001193125-25-283006.md) | [(7.9) d](/filings/0001193125-26-134714.md) | [(3.6)](/filings/0001193125-26-226795.md) | [(7.9)](/filings/0001193125-26-352362.md) | [(5.9)](/filings/0001193125-25-283006.md) | [(5.0) d](/filings/0001193125-26-134714.md) | [(8.4)](/filings/0001193125-26-226795.md) | [(5.0)](/filings/0001193125-26-352362.md) | | Diluted EPS | $ per share | [(0.33)](/filings/0000950170-24-127232.md) | not reported | [(1.64)](/filings/0000950170-25-072501.md) | [(14.09)](/filings/0000950170-25-108855.md) | [(48.73)](/filings/0001193125-25-283006.md) | not reported | [(30.37)](/filings/0001193125-26-226795.md) | [(82.58)](/filings/0001193125-26-352362.md) | [(1.64)](/filings/0001193125-25-283006.md) | not reported | [(11.69)](/filings/0001193125-26-226795.md) | [(3.05)](/filings/0001193125-26-352362.md) | | Basic EPS | $ per share | [(0.33)](/filings/0000950170-24-127232.md) | not reported | [(1.64)](/filings/0000950170-25-072501.md) | [(14.09)](/filings/0000950170-25-108855.md) | [(48.73)](/filings/0001193125-25-283006.md) | not reported | [(30.37)](/filings/0001193125-26-226795.md) | [(82.58)](/filings/0001193125-26-352362.md) | [(1.64)](/filings/0001193125-25-283006.md) | not reported | [(11.69)](/filings/0001193125-26-226795.md) | [(3.05)](/filings/0001193125-26-352362.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: not reported - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [0.4](/filings/0001193125-23-280859.md) | [2.1](/filings/0000950170-25-054303.md) | [1.0](/filings/0000950170-24-060596.md) | [0.5](/filings/0000950170-24-096912.md) | [4.3](/filings/0000950170-24-127232.md) | [1.1](/filings/0001193125-26-134714.md) | [0.8](/filings/0000950170-25-072501.md) | [2.3](/filings/0000950170-25-108855.md) | [0.9](/filings/0001193125-25-283006.md) | [0.3](/filings/0001193125-26-352362.md) | [0.1](/filings/0001193125-26-226795.md) | [0.6](/filings/0001193125-26-352362.md) | | Current assets | $m | [0.5](/filings/0001193125-23-280859.md) | [2.9](/filings/0000950170-25-054303.md) | [2.1](/filings/0000950170-24-060596.md) | [1.6](/filings/0000950170-24-096912.md) | [5.1](/filings/0000950170-24-127232.md) | [2.7](/filings/0001193125-26-134714.md) | [2.6](/filings/0000950170-25-072501.md) | [3.8](/filings/0000950170-25-108855.md) | [2.3](/filings/0001193125-25-283006.md) | [1.4](/filings/0001193125-26-352362.md) | [1.7](/filings/0001193125-26-226795.md) | [1.8](/filings/0001193125-26-352362.md) | | Total assets | $m | [36.0](/filings/0001193125-23-280859.md) | [5.3](/filings/0000950170-25-054303.md) | [4.4](/filings/0000950170-24-060596.md) | [3.8](/filings/0000950170-24-096912.md) | [7.3](/filings/0000950170-24-127232.md) | [25.7](/filings/0001193125-26-134714.md) | [33.7](/filings/0000950170-25-072501.md) | [34.7](/filings/0000950170-25-108855.md) | [33.0](/filings/0001193125-25-283006.md) | [31.6](/filings/0001193125-26-352362.md) | [31.5](/filings/0001193125-26-226795.md) | [31.3](/filings/0001193125-26-352362.md) | | Current liabilities | $m | [8.1](/filings/0001193125-23-280859.md) | [37.1](/filings/0000950170-25-054303.md) | [35.2](/filings/0000950170-24-060596.md) | [35.6](/filings/0000950170-24-096912.md) | [30.1](/filings/0000950170-24-127232.md) | [28.3](/filings/0001193125-26-134714.md) | [29.3](/filings/0000950170-25-072501.md) | [30.2](/filings/0000950170-25-108855.md) | [26.0](/filings/0001193125-25-283006.md) | [22.4](/filings/0001193125-26-352362.md) | [22.2](/filings/0001193125-26-226795.md) | [18.0](/filings/0001193125-26-352362.md) | | Total liabilities | $m | [17.9](/filings/0001193125-23-280859.md) | [37.2](/filings/0000950170-25-054303.md) | [35.3](/filings/0000950170-24-060596.md) | [35.7](/filings/0000950170-24-096912.md) | [30.2](/filings/0000950170-24-127232.md) | [28.4](/filings/0001193125-26-134714.md) | [30.7](/filings/0000950170-25-072501.md) | [31.5](/filings/0000950170-25-108855.md) | [27.5](/filings/0001193125-25-283006.md) | [23.6](/filings/0001193125-26-352362.md) | [23.4](/filings/0001193125-26-226795.md) | [19.1](/filings/0001193125-26-352362.md) | | Shareholders' equity | $m | [(31.3)](/filings/0000950170-24-127232.md) | [(31.9)](/filings/0001193125-26-134714.md) | [(30.8)](/filings/0001193125-25-283006.md) | [(31.8)](/filings/0001193125-25-283006.md) | [(22.8)](/filings/0001193125-25-283006.md) | [(2.8)](/filings/0001193125-26-352362.md) | [2.9](/filings/0001193125-26-352362.md) | [3.0](/filings/0001193125-26-352362.md) | [5.4](/filings/0001193125-25-283006.md) | [8.1](/filings/0001193125-26-352362.md) | [8.1](/filings/0001193125-26-352362.md) | [12.2](/filings/0001193125-26-352362.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [(1,761) d](/filings/0000950170-24-127232.md) | [4,257 d](/filings/0000950170-25-054303.md) | [(2,117)](/filings/0000950170-25-072501.md) | [(1,696) d](/filings/0000950170-25-108855.md) | [(1,550) d](/filings/0001193125-25-283006.md) | [(4,212) d](/filings/0001193125-26-134714.md) | [(4,974)](/filings/0001193125-26-226795.md) | [(4,049) d](/filings/0001193125-26-352362.md) | [(4,393) d](/filings/0001193125-25-283006.md) | [(2,290) d](/filings/0001193125-26-134714.md) | [(5,501)](/filings/0001193125-26-226795.md) | [(3,865) d](/filings/0001193125-26-352362.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities ## Shares | Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | thousands of shares | [6,382](/filings/0000950170-24-060596.md) | [6,460](/filings/0000950170-24-096912.md) | [2,394](/filings/0000950170-24-127232.md) | [2,612](/filings/0000950170-25-072501.md) | [281](/filings/0000950170-25-108855.md) | [316](/filings/0001193125-25-283006.md) | [120](/filings/0001193125-26-226795.md) | [96.0](/filings/0001193125-26-352362.md) | [3,591](/filings/0001193125-25-283006.md) | [720](/filings/0001193125-26-226795.md) | [1,627](/filings/0001193125-26-352362.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.